Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial
暂无分享,去创建一个
E. Perez | H. Rugo | S. Im | J. O’Shaughnessy | C. Twelves | A. Awada | J. Cortés | M. Tagliaferri | A. Hannah | U. Hoch | J. Buchanan | Carol Zhao | Denise Tomkinson